Skip to content
    Inve.money
    Earnings calls

    Dr Agarwal's Hea concall ledger

    Every earnings call for AGARWALEYE — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    AGARWALEYE · 6 transcripts · Healthcare · latest Q4 FY26
    Q4 FY26Published 21 May 2026Call held 21 May 2026

    AGARWALEYE Q4 FY26 Earnings Call Transcript & Analysis

    FY26 Revenue from Operations₹2,080 cr+22% YoYFY26 EBITDA Margin28.9%FY26 PAT₹168 cr+52% YoYFY26 PAT Margin7.9%FY26 Total Income₹2,125 cr+21% YoY

    FY26 Revenue from Operations ₹2,080 cr (+22% YoY); FY26 EBITDA Margin 28.9%; FY26 PAT ₹168 cr (+52% YoY). Full year revenue from operations grew 21.6% YoY to INR 2,080 crores, crossing the INR 2,000 crore mark for the first time.

    Read full transcript & analysis
    Q3 FY26Published 04 Feb 2026Call held 04 Feb 2026

    AGARWALEYE Q3 FY26 Earnings Call Transcript & Analysis

    Revenue from Operations₹1,516 cr+21% YoYEBITDA Margin28.4%Profit After Tax₹118 cr+74% YoYPAT Margin7.6%Total Income₹1,548 cr+21% YoY

    Revenue from Operations (9M FY26) ₹1,516 cr (+21% YoY); EBITDA Margin (9M FY26) 28.4%; Profit After Tax (9M FY26) ₹118 cr (+74% YoY). 9M FY26 total income reached ₹1,548 crores, a 20.8% YoY increase.

    Read full transcript & analysis
    Q2 FY26Published 31 Oct 2025Call held 31 Oct 2025

    AGARWALEYE Q2 FY26 Earnings Call Transcript & Analysis

    H1 Total Income₹1,007 cr+20% YoYH1 Revenue from Operations₹986 cr+20% YoYH1 IndAS EBITDA₹285 cr+25% YoYH1 IndAS EBITDA Margin28.3%H1 PAT₹75 cr+88% YoY

    H1 Total Income ₹1,007 cr (+20% YoY); H1 Revenue from Operations ₹986 cr (+20% YoY); H1 IndAS EBITDA ₹285 cr (+25% YoY). H1 FY26 total income reached INR1,007 crores, up 20.2% YoY.

    Read full transcript & analysis
    Q1 FY26Published 28 Aug 2025Call held 28 Aug 2025

    AGARWALEYE Q1 FY26 Earnings Call Transcript & Analysis

    Preferential Allotment Amount₹70 crAEHL Equity Shares Post Allotment48.3 lakh sharesAEHL Promoter Holding Post Allotment72.7%AEHL Public Holding Post Allotment27.3%Combined Entity Share Capital₹33.13 cr

    Preferential Allotment Amount ₹70 cr; AEHL Equity Shares Post Allotment 48.3 lakh shares; AEHL Promoter Holding Post Allotment 72.7%. Proposed merger of Dr. Agarwal's Eye Hospital (AEHL) into Dr. Agarwal's Health Care (AHCL) announced.

    Read full transcript & analysis
    Q4 FY25Published 29 May 2025Call held 29 May 2025

    AGARWALEYE Q4 FY25 Earnings Call Transcript & Analysis

    FY25 Revenue from operations₹1,711 cr+28% YoYFY25 EBITDA₹502 cr+24% YoYFY25 EBITDA Margin28.6%FY25 PAT₹110 cr+16% YoYFY25 PAT Margin6.3%

    FY25 Revenue from operations ₹1,711 cr (+28% YoY); FY25 EBITDA ₹502 cr (+24% YoY); FY25 EBITDA Margin 28.6%. FY25 Revenue from operations grew 28.4% YoY to INR1,711 crores.

    Read full transcript & analysis